ENDO 2025 in San Francisco, Calif., is one for the history books! Now it’s time to look ahead to the Society’s other marquee meetings: Clinical Endocrinology Update (CEU) 2025 and Endocrine Board Review (EBR) 2025 and, both taking place online this fall.
Member volunteers and staff have been hard at work preparing these meetings designed primarily for our clinician members. At the same time, the Society is developing a set of exciting meetings for our research members in the coming year.
As any long-time member knows, the Society takes seriously its commitment to creating top-notch meetings.
CEU and EBR offer many of the same great benefits as our annual meeting, with unparalleled learning opportunities led by some of the brightest minds in our field. For a growing number of our clinician members, CEU and EBR have become must-attend events.
CEU Provides Knowledge on Latest Advancements in Care
The larger of the two fall meetings is Clinical Endocrinology Update (CEU) 2025, held October 23 – 25. This meeting offers sessions on the latest advancements in hormone care across nine topical tracks. Attendees can participate in sessions of their choice and chat with speakers in real time. If you miss a session, you can catch up by viewing one of the recordings. The program includes:
- October 23 – Day One: Focus on diabetes management, pituitary, adrenal disorders, as well as diabetes technology, insulin therapy, and complex case management of pituitary diseases.
- October 24 – Day Two: Covers adrenal, thyroid, and reproductive care, featuring sessions on adrenal incidentalomas, hypogonadism, hormone therapy, and thyroid guidelines.
- October 25 – Day Three: Highlights obesity, lipid management, and thyroid disorders, including GLP-1 receptor agonists, type 2 diabetes in youth, NASH treatment, and thyroid hormone use.
Because it’s virtual, attendees can participate from anywhere in the world. No other meeting that I’m aware of can compare in terms of content and convenience. But don’t take my word for it. Our member volunteers who have designed CEU 2025 have the best take on the program.
What makes CEU especially exciting is the opportunity to learn directly from the leading experts and gain insight into the latest advancements in the diagnosis and management of endocrine disorders, notes Leonor Corsino, MD, MHS.
“In today’s fast-paced clinical environment, many endocrinologists find it difficult to stay current with the rapidly evolving body of research and emerging clinical guidelines,” she says. “CEU serves as a critical bridge between scientific advancement and day-to-day clinical practice.”
The meeting achieves this, she adds, by offering targeted sessions on high-impact topics, such as the latest in diabetes technology, individualized treatment approaches, and patient-centered care.
“Importantly, it offers a structured and efficient way for busy healthcare professionals to access up-to-date information, ensuring that their clinical decisions remain aligned with the latest standards and ultimately enhancing patient outcomes,” Corsino says.
CEU 2025 offers up to 27 AMA PRA Category 1 Credits™. Eligible physicians may also claim up to 9 ABIM MOC Points.
EBR Offers Proven System for Success
Preceding CEU in September is Endocrine Review Board (EBR) 2025, our annual preparation program for people taking the American Board of Internal Medicine (ABIM) board certification in endocrinology, diabetes, and metabolism.
EBR is a comprehensive training program that includes a hard-bound book, online practice exams, and live Q&A sessions with subject-matter experts, on September 5 – 7. The program is considered the gold standard in preparing for the ABIM. We’re so confident in the program that the Society even guarantees success or attendees will receive free registration for EBR 2026.
This program serves as a vital tool in the Society’s efforts to boost the pipeline of new endocrinologists, giving early-career clinicians the confidence and knowledge they need to gain their board certification.
Again, our member volunteers who have designed the program have seen its success firsthand.
EBR offers many excellent benefits to first-time exam takers, says Sangeeta Kashyap, MD.
“Although there are many review courses, this is a vital part of board preparation,” she says, noting it is “convenient and fairly short” compared with other courses.
Kaniksha Desai, MD, ECNU, adds that EBR “translates complex endocrine concepts into clear, memorable takeaways for test day.”
EBR also highlights new advances in endocrinology, including this year’s focus on thyroid care, which is now board relevant. Topics that will be addressed include molecular diagnostics, dynamic surveillance strategies, and new procedures such as radiofrequency ablation.
CEU and EBR offer many of the same great benefits as our annual meeting, with unparalleled learning opportunities led by some of the brightest minds in our field. For a growing number of our clinician members, CEU and EBR have become must-attend events.
“EBR provides a structured roadmap that takes the guesswork out of studying,” Desai says. “It helps build test confidence by teaching not only what to know, but how to think through tricky board scenarios.”
EBR 2025 provides up to 64 AMA PRA Category 1 Credits and 64 ABIM MOC points.
Research Meetings Are Under Development
While these meetings are set for the fall, the Society also is busy developing new meetings of interest to our basic science research members that are rapidly gaining momentum.
One of particular interest to me is the International Conference on Steroid Hormones and Receptors (SHR). Along with Eric Prossnitz (University of New Mexico), I was honored to co-chair the inaugural 2024 meeting under the Society’s auspices that was held in Albuquerque, N.M., at the University of New Mexico Comprehensive Cancer Center. SHR 2024 focused on the role of steroid hormone receptors (SRs) in health and disease and featured sessions covering a broad range of SR actions in animal and human physiology, including neurobiology, cardiology, immunology, reproduction, and cancer.
The next SHR will take place in 2026, and the Society will announce details at a forthcoming date.
I’m already excited about this event, as SHR brings together world-class scientists, researchers, physicians, post-doctoral trainees and students working in various disciplines of steroid hormone and receptor actions in biology and medicine from all over the world.
Whether for clinicians or researchers, I look forward to all our Society meetings.
Loading ...